What is hearX?
hearX operates at the intersection of medical technology and consumer accessibility, aiming to democratize healthy hearing worldwide. The company's dual-division structure encompasses a B2B offering that provides cutting-edge clinical hearing health solutions to professionals and retailers, alongside its B2C Lexie Hearing platform. Lexie Hearing distinguishes itself by delivering direct-to-consumer/over-the-counter hearing aids through an inclusive remote care model, coupled with a unique rewards program designed to enhance customer satisfaction and reduce product returns. Leveraging advanced smart technology, artificial intelligence, and big data analytics, hearX has developed a comprehensive suite of digital tools for the detection, diagnosis, and treatment of hearing loss, making cost-effective hearing solutions available globally.
How much funding has hearX raised?
hearX has raised a total of $3.8M across 1 funding round:
Series A
$3.8M
Series A (2021): $3.8M with participation from Sphere Holdings, Futuregrowth, Bose Ventures, and Havac
Key Investors in hearX
Sphere Holdings
Sphere Holdings is an investment entity likely focused on strategic growth opportunities within various sectors, potentially including technology and healthcare, given their participation in hearX's funding.
Futuregrowth
Futuregrowth is a prominent asset manager in South Africa, known for its impact investing and focus on sustainable development, suggesting an interest in companies with strong social and technological missions like hearX.
Bose Ventures
Bose Ventures is the venture capital arm of Bose Corporation, indicating a strategic interest in audio technology, consumer electronics, and innovative health solutions that align with Bose's core competencies.
What's next for hearX?
With the recent influx of major strategic investment, hearX is poised for accelerated scaling and enhanced market penetration. The company's focus on innovation, particularly in AI and data-driven hearing health solutions, positions it for continued leadership in the medtech space. This capital infusion is anticipated to bolster its B2C offerings, potentially expanding the reach of the Lexie Hearing platform and its novel rewards program. Furthermore, the enterprise-level funding suggests a strategic push to solidify its B2B partnerships and further develop its clinical solutions, reinforcing hearX's mission to make hearing accessible to everyone, everywhere.
See full hearX company page
